IWC
CRDL

Integrated Wealth Concepts’s Cardiol Therapeutics CRDL Stock Holding History

Integrated Wealth Concepts’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12K Buy
+2,000
New +$2.53K ﹤0.01% 5338

Other funds holding CRDL

MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $3.2B AUM 23.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Integrated Wealth Concepts's CRDL Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Cardiol Therapeutics (CRDL) in Q2 2026: 2,000 shares worth $2.12K. The stake represents ﹤0.01% of the portfolio and ranks #5338 among its holdings.

52 funds tracked by Wall St. Rank hold CRDL as of Q2 2026.

  • Integrated Wealth Concepts held 2,000 shares of Cardiol Therapeutics worth $2.12K as of Q2 2026.
  • Cardiol Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • Cardiol Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5338 holding.
  • 52 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.